Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116682714 | 11668271 | 4 | F | 20151002 | 20160831 | 20151027 | 20160906 | EXP | US-UNITED THERAPEUTICS-UNT-2015-013370 | UNITED THERAPEUTICS | 76.53 | YR | F | Y | 69.84000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116682714 | 11668271 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 36-72 ?G, QID | 2100675 | 22387 | INHALATION GAS | QID | ||||||||
| 116682714 | 11668271 | 2 | SS | TYVASO | TREPROSTINIL | 1 | 36 ?G, QID | 22387 | 36 | UG | INHALATION GAS | QID | |||||||
| 116682714 | 11668271 | 3 | SS | TYVASO | TREPROSTINIL | 1 | 72 ?G, QID | 22387 | 72 | UG | INHALATION GAS | QID | |||||||
| 116682714 | 11668271 | 4 | SS | REVATIO | SILDENAFIL CITRATE | 1 | UNK UNK, QID | 0 | QID | ||||||||||
| 116682714 | 11668271 | 5 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 9 TIMES DAILY | A56350 1 | 0 | 20 | MG | ||||||||
| 116682714 | 11668271 | 6 | C | OPSUMIT | MACITENTAN | 1 | UNK | 0 | |||||||||||
| 116682714 | 11668271 | 7 | C | COZAAR | LOSARTAN POTASSIUM | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 116682714 | 11668271 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 116682714 | 11668271 | 9 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 75-325 MG, Q6H | 0 | QID | ||||||||||
| 116682714 | 11668271 | 10 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD | ||||||||
| 116682714 | 11668271 | 11 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 116682714 | 11668271 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 80 MG, ONE AND HALF DAILY | 0 | 80 | MG | |||||||||
| 116682714 | 11668271 | 13 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 150 MG, NIGHTLY | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116682714 | 11668271 | 1 | Pulmonary arterial hypertension |
| 116682714 | 11668271 | 4 | Cardiac disorder |
| 116682714 | 11668271 | 5 | Pulmonary hypertension |
| 116682714 | 11668271 | 6 | Product used for unknown indication |
| 116682714 | 11668271 | 7 | Cardiac disorder |
| 116682714 | 11668271 | 8 | Cardiac disorder |
| 116682714 | 11668271 | 9 | Cardiac disorder |
| 116682714 | 11668271 | 10 | Cardiac disorder |
| 116682714 | 11668271 | 11 | Cardiac disorder |
| 116682714 | 11668271 | 12 | Cardiac disorder |
| 116682714 | 11668271 | 13 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116682714 | 11668271 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116682714 | 11668271 | Ankle fracture | |
| 116682714 | 11668271 | Fall | |
| 116682714 | 11668271 | Lower limb fracture | |
| 116682714 | 11668271 | Product use issue | |
| 116682714 | 11668271 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116682714 | 11668271 | 1 | 20140731 | 0 | ||
| 116682714 | 11668271 | 4 | 2013 | 0 |